Editorial Board
Dr. Guru Prasad Maiti PhD
Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation · USA
Editorial leadership for Journal of Cancer Genetics And Biomarkers ISSN 2572-3030
Research interests
- &Nbsp;Rna
- &Nbsp;Cancer Biology
- &Nbsp;Cell Culture
- &Nbsp;Gene Expression
- &Nbsp;Dna
- &Nbsp;Western Blot Analysis
- &Nbsp;Immunohistochemistry
- &Nbsp;Immunofluorescence
- &Nbsp;Electrophoresis
Biography
- University of Oklahoma Health Sciences Center, Stephenson Cancer CenterUnited States (February 2016 - 2023)
- Texas tech University Health Science Center, Lubbock, United State, Department of Anesthesiology (April 2015 - January 2016)
- University of Kalyani, Department of Molecular Biology and BiotechnologyKalyani, India (August 2014 - April 2015)
Selected publications
- Discovery and Functional Characterization of Two Regulatory Variants Underlying Lupus Susceptibility at 2p13.1
- Idelalisib activates AKT via increased recruitment of PI3Kδ/PI3Kβ to BCR signalosome while reducing PDK1 in post-therapy CLL cells
- SIRT3 overexpression and epigenetic silencing of catalase regulate ROS accumulation in CLL cells activating AXL signaling axis
- Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis
- Short-duration hyperoxia causes genotoxicity in mouse lungs: Protection by volatile anesthetic isoflurane
Considering JCGB for your work?
This journal is guided by Dr. Guru Prasad Maiti (Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.